Feb 24, 2026, 5:55 AM EST - 2 hours ago
Novo Nordisk's stock dropped 16% on February 23rd after clinical trial results indicated that its experimental weight-loss medication, CagriSema, did not perform as well as Eli Lilly's competing drug,...
NVO
MMED
HIMS
IBM
OIH
PXJ
UCO